shr-3167
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 9, 2023 (NCT05996380)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07032688 | Phase 1 | Aug 11, 2025 | Hengrui Therapeutics, Inc. |
| NCT07018453 | Phase 2 | Jul 16, 2025 | Hengrui Therapeutics, Inc. |
| NCT06688123 | Phase 2 | Nov 30, 2024 | Hengrui Therapeutics, Inc. |
| NCT05996380 | Phase 1 | Jun 9, 2023 | Hengrui Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1